Home

Natco Pharma Ltd Quarterly Result

Image

Natco Pharma Ltd

NSE: NATCOPHARM

Net Profit - Last Quarter

₹ 676.5 Cr.

Last updated on: Jan 15, 2025

Key Highlights

  • The revenue of Natco Pharma Ltd for the Sep '24 is ₹ 1434 crore as compare to the Jun '24 revenue of ₹ 1410 crore. This represent the growth of 1.7154657%.
  • The ebitda of Natco Pharma Ltd for the Sep '24 is ₹ 868.1 crore as compare to the Jun '24 ebitda of ₹ 852.9 crore. This represent the growth of 1.7821492%.
  • The net profit of Natco Pharma Ltd for the Sep '24 is ₹ 676.5 crore as compare to the Jun '24 net profit of ₹ 668.5 crore. This represent the growth of 1.196709%.

Results Analysis

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
15 Jan 20251220.6
14 Jan 20251255.8
13 Jan 20251212.35
10 Jan 20251235.5
09 Jan 20251288.95
08 Jan 20251318.7
07 Jan 20251326.6
06 Jan 20251310.15
03 Jan 20251366.85
02 Jan 20251385.35

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Natco Pharma Ltd News Hub

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad

Read more

04 Sep 2024

Natco Pharma fixes record date for second interim dividend

Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The

Read more

12 Aug 2024

Board of Natco Pharma recommends dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2

Read more

12 Aug 2024

Natco Pharma schedules AGM

Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30

Read more

12 Aug 2024

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

June 2024

TranscriptPPT

May 2024

PPT

June 2023

TranscriptPPT

June 2022

TranscriptPPT

July 2021

TranscriptPPT

FAQs for Quarterly Results of Natco Pharma Ltd

What key financial metrics are included in Natco Pharma Ltd's quarterly results?

Key financial metrics in Natco Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Natco Pharma Ltd announce its quarterly results?

Natco Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Natco Pharma Ltd's quarterly performance impact its stock price?

Natco Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Natco Pharma Ltd's quarterly results on dividends?

The impact of Natco Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Natco Pharma Ltd's quarterly results?

Yes, Natco Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions